Medullary Carcinoma
Medullary Carcinoma is a rare malignancy that can affect the thyroid gland or breast tissue.
It may occur sporadically or due to inherited RET gene mutations. Early symptoms include neck mass, thyroid enlargement, or breast lump. Timely diagnosis via imaging, biopsy, and genetic testing allows surgical, radiotherapeutic, and systemic treatment for optimal patient outcomes.
Causes and Risk Factors of Medullary Carcinoma
Medullary Carcinoma can arise sporadically or due to genetic factors.
- RET gene mutation: Inherited mutations significantly increase risk.
- Family history of thyroid or breast cancer
- Age: Usually occurs in adults between 40-60 years
Symptoms and Clinical Features
Patients may notice early warning signs such as:
- Palpable neck mass or thyroid nodule
- Breast lump: Firm, painless lump in the breast tissue
- Voice changes or difficulty swallowing
- Unexplained weight loss and fatigue
Treatment Options for Medullary Carcinoma
Treatment strategy depends on tumor type, location, and stage.
- Surgical resection: Total thyroidectomy or lumpectomy depending on site.
- Radiotherapy and chemotherapy as needed
- Targeted therapy for RET-positive tumors
Why Choose Us for Medullary Carcinoma
CureU Healthcare provides expert oncology care, genetic counseling, advanced diagnostics, and personalized treatment plans to achieve the best outcomes.
Conclusion
Medullary Carcinoma is rare but treatable with early intervention. CureU Healthcare ensures comprehensive care including surgery, targeted therapy, and follow-up.
